These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 25572638)
1. Human papillomavirus serology and tobacco smoking in a community control group. Kelsey KT; Nelson HH; Kim S; Pawlita M; Langevin SM; Eliot M; Michaud DS; McClean M BMC Infect Dis; 2015 Jan; 15():8. PubMed ID: 25572638 [TBL] [Abstract][Full Text] [Related]
2. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. Applebaum KM; Furniss CS; Zeka A; Posner MR; Smith JF; Bryan J; Eisen EA; Peters ES; McClean MD; Kelsey KT J Natl Cancer Inst; 2007 Dec; 99(23):1801-10. PubMed ID: 18042931 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618 [TBL] [Abstract][Full Text] [Related]
4. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822 [TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection. Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236 [TBL] [Abstract][Full Text] [Related]
7. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711 [TBL] [Abstract][Full Text] [Related]
8. Case-control study of human papillomavirus and oropharyngeal cancer. D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927 [TBL] [Abstract][Full Text] [Related]
9. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study. Anderson KS; Gerber JE; D'Souza G; Pai SI; Cheng JN; Alam R; Kesiraju S; Chowell D; Gross ND; Haddad R; Gillison ML; Posner M Oral Oncol; 2015 Aug; 51(8):751-8. PubMed ID: 26094591 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma. Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084 [TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820 [TBL] [Abstract][Full Text] [Related]
13. InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. Sitas F; Egger S; Urban MI; Taylor PR; Abnet CC; Boffetta P; O'Connell DL; Whiteman DC; Brennan P; Malekzadeh R; Pawlita M; Dawsey SM; Waterboer T; J Natl Cancer Inst; 2012 Jan; 104(2):147-58. PubMed ID: 22228147 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S; J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239 [TBL] [Abstract][Full Text] [Related]
15. Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection. Wiley DJ; Wiesmeier E; Masongsong E; Gylys KH; Koutsky LA; Ferris DG; Barr E; Yu Rao J; Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):915-20. PubMed ID: 16702370 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M; Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck. Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. Kreimer AR; Johansson M; Waterboer T; Kaaks R; Chang-Claude J; Drogen D; Tjønneland A; Overvad K; Quirós JR; González CA; Sánchez MJ; Larrañaga N; Navarro C; Barricarte A; Travis RC; Khaw KT; Wareham N; Trichopoulou A; Lagiou P; Trichopoulos D; Peeters PH; Panico S; Masala G; Grioni S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Laurell G; Hallmans G; Manjer J; Ekström J; Skeie G; Lund E; Weiderpass E; Ferrari P; Byrnes G; Romieu I; Riboli E; Hildesheim A; Boeing H; Pawlita M; Brennan P J Clin Oncol; 2013 Jul; 31(21):2708-15. PubMed ID: 23775966 [TBL] [Abstract][Full Text] [Related]
20. Characterization of human papillomavirus antibodies in individuals with head and neck cancer. Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]